Home » TM TO MANUFACTURE REAGENTS FOR INTERGENETICS
TM TO MANUFACTURE REAGENTS FOR INTERGENETICS
Tm Bioscience announced it has signed a five-year agreement to supply custom Tag-It reagents to InterGenetics for OncoVue. According to InterGenetics, OncoVue has been developed as a genetic-based breast cancer risk test relevant to all women. The agreement anticipates InterGenetics will purchase a minimum of $7.5 million in reagents from Tm over the five-year period.
ArriveNet
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May